For years, researchers investigating insulin as a potential Alzheimer’s treatment have faced a frustrating pattern: promising ...

Novo Nordisk has introduced a once-weekly insulin option in India, opening discussions around how newer therapies could ...

Novo Nordisk has introduced Awiqli (insulin icodec) in India, the world's first once-weekly basal insulin, reducing annual ...

Insulin therapy is a cornerstone of management in type 2 diabetes when oral agents and lifestyle interventions no longer achieve glycaemic targets. The progressive decline in pancreatic β-cell ...

By Rishika Sadam July 9 (Reuters) - Danish drugmaker Novo Nordisk launched its weekly basal insulin injection, Awiqli, in ...

The launch marks a major step in diabetes care, as patients who currently require one basal insulin injection every day may ...

India has become one of the first countries to introduce Awiqli, the world’s first once-weekly basal insulin for adults with ...

Modular Medical Inc. MODD, on Tuesday, announced that the first patients have completed onboarding and training and are now ...

Awiqli offers adults with diabetes fewer injections while maintaining effective blood sugar control through weekly dosing.

New research presented at the International Society for Stem Cell Research (ISSCR) 2026 Annual Meeting explores an approach ...

One injection a week instead of one every day. Danish drugmaker Novo Nordisk has launched Awiqli, or insulin icodec, in India ...